JOIN NOW

Why not join CURE today? You already belong!

Good for bioscience in Connecticut. Good for you.
JOIN NOW

The CURE Calendar


Sep
21
Wed
BEACON-Medtronic Seminar @ Medronic (formerly Covidien)
Sep 21 @ 5:00 am – 7:30 pm

This event highlights all things medical device, with two presentations from Medtronic experts.

Networking Reception 5:00-5:30 PM           

Presentations 5:30-7:30 PM

Directions and parking information will be sent with each RSVP.

NO CHARGE TO ATTEND, BUT RSVP REQUIRED BY September 15 – No Exceptions!

RSVP to:  860-547-1995 or Toll Free: 877-723-2266 or  Email:  lsnow@beaconalliance.org

Bioscience ClubhouseCT & The Town of Branford Present: A Bioscience & Beer Mixer @ Stony Creek Brewery
Sep 21 @ 4:30 pm – 7:00 pm

(Additional parking available at the Metro-North train station.)

Cheers to Bioscience!

Come out and join us to learn more about the new and growing bioscience companies in the Branford area at this special Bioscience ClubhouseCT event. Network and forge new partnerships over a terrific Stony Creek craft beer. We’ll also be sampling some of the area’s finest pizza.

We invite the first 5 companies who apply to kgipson@cureconnect.org to present 5 minute informal (no slides) introductions about who they are and what they do. We invite ALL companies to present posters which will be on display throughout the event.

Centrally located on the Long Island Sound with more than 20 miles of shoreline, Branford has a quality of life and sense of community that is second to none. With a healthy business climate and an existing diverse community of life sciences, manufacturing, healthcare and service industries, Branford is a vibrant place for bioscience.

Thank you to our Sponsors:
             

WSGR

Sep
25
Sun
The Science of Stability Conference @ Renaissance Newark Airport Hotel
Sep 25 – Sep 27 all-day
Sep
28
Wed
BioHaven Presents: Bioscience Investor Outlook: 2016 Trend Report and 2017… @ Anylan Center at Yale
Sep 28 @ 4:00 pm – 6:00 pm

Please join us and our diverse, deeply experienced panel of bioscience investors as they explain the venture capital trends of 2016 as well as discuss a look into the future as to where the capital will be flowing in 2017.  Hosted by Harry Penner, Director, CURE and moderated byDormer Stephen, Partner, Shipman & Goodwin, panelists include Christy Shaffer, General Partner, Hatteras Venture Partners, Kevin Rakin, Co-Founder of HighCape Partners, Tim Shannon, General Partner, Canaan Parters, Mark Dempster, Managing Director, Stifel, Nicolaus, Weisel and one additional panelist will lead this exciting conversation regarding bioscience investing, helping our region cultivate and advance biomedical innovation and services to support new medical advances.

Thank you to our sponsors:

    

     

   

Oct
4
Tue
Bioscience ClubhouseCT Presents: PITCH at Stamford Innovation Center – UCONN and Yale’s Collaborative to Spin Out Drug Discovery Start-Ups @ Stamford Innovation Center
Oct 4 @ 4:30 pm – 6:00 pm

The Program in Innovative Therapeutics for Connecticut’s Health, also known as PITCH, will create new biotech companies in Connecticut based on CT’s academic biomedical research. Building on significant academic infrastructure and experienced leadership bridging the worlds of academia, biopharma and venture capital, the PITCH program will educate and guide the state’s academic researchers to unlock Connecticut’s large potential for biotech/biopharma creation. In this highly collaborative endeavor, PITCH will translate Connecticut’s research into new ventures and jobs.

Host:


Dr. Froshauer is President and CEO of CURE (Connecticut United for Research Excellence, Inc.) and President of CURE Innovations, LLC.  She has spent over 27 years in biopharmaceuticals research and development. She is an experienced scientist, pharmaceutical executive, mentor, entrepreneur and angel investor with skill at connecting academic expertise and technology with the commercial sector.   Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT funded group, SECT Tech, the Creative Arts Workshop and the Angel Investor Forum.  Prior to joining CURE, Dr. Froshauer was Director of the Technology Exchange Portal at the University of Connecticut’s Office of Economic Development. In this role Susan assisted Connecticut-based entrepreneurs and organizations with initiatives that train students, create jobs and contribute to economic development. She connected ideas with business expertise, business plans with investors and industry with scholars.

Until 2010, Susan served as President and CEO of Rib-X Pharmaceuticals, which she co-founded with Yale scientists in New Haven in 2000. Under her leadership, Rib-X raised more than $160 million in private equity, bridge financing and government grants and built an emerging pipeline of antibiotics to treat serious antibiotic-resistant bacterial infections. Prior to Rib-X, for 5 years Susan served as a member of Pfizer’s Strategic Alliance Group where she was part of a team involved in the creation of a $200 million investment portfolio that transformed the Pfizer global research and development strategy, helping the company identify new resources for drug discovery.   Prior to work at Pfizer in business development.  Dr. Froshauer ran a drug discovery research lab responsible to identify new classes of antibiotics.

Susan received a Ph.D. in Microbiology and Molecular Genetics from Harvard University and a B. A. from Connecticut College. She performed post-doctoral research at Yale Medical School in the Department of Cell Biology as a Jane Coffin Child’s Fellow.

Presenters:

Janie Merkel is the Director of the PITCH program and is passionate about helping academic scientists best apply technologies as part of their quests to develop new treatments for unmet medical needs, with no limits regarding the disease area or application. She leads a 12-person team of biologists and chemists at the Yale Center for Molecular Discovery at Yale University, where she has been for 10 years. University of Connecticut faculty bring major strengths to PITCH with robust life science programs and pharmaceutical development expertise. Janie was an undergraduate at Dartmouth College, earned her Ph.D. at Yale in Molecular Biophysics and Biochemistry and spent 6 years in biotechnology companies prior to joining Yale.

 

John C. Deacon, Ph.D. received his B.A. from the University of California, Berkeley, and his Ph.D. in Molecular, Cellular and Developmental Biology from the University of Colorado, Boulder. As an Associate Research Scientist in the lab of Donald Engelman at Yale University, he investigates methods of targeting therapies to the acidic microenvironment of solid tumors. His invention, a platform technology that produces Tumor Activated Prodrugs (TAPs) of chemotherapeutic agents, controls drug uptake into cells, preventing these toxins from harming healthy tissues in the body. The TAP platform may offer near term solutions for reducing the side effects a wide range of cancers, and is being developed towards clinical and commercial realization with the help of PITCH.

Michael Lynes, Ph.D has served as Head of the Department of Molecular and Cell Biology at the University of Connecticut for the past four years.  He was educated at Colby College, and at the University of North Carolina, Chapel Hill where he earned his Ph.D. in Genetics, with a specialization in Immunology.  While at UCONN, he created the Flow Cytometry facility of the Biotechnology Center, and was Co-head of that facility for many years.  His research has spanned the study of genes that regulate the progression of leukemias, and the control of both normal and abnormal immune  responses.  In the course of these studies, he identified an unanticipated role in immuno-regulation for a stress response protein called metallothionein, and was able to show that this protein can be manipulated with an antibody made in his research laboratory as a therapeutic intervention for inflammatory bowel disease and Crohn’s disease.  Dr. Lynes has patents for this therapeutic intervention, and for instruments that measure in vitro cellular movement in real time and that enable thousands of simultaneous analyses of cellular behavior in a microarray format.  He was recognized with a NASA Space Act award for one of these inventions.

Sponsors:

  

                    

  

                    

Serial Entrepreneur: David Scheer

Biotech Entrepreneur Kevin Rakin:
The Business of Science

A CT Bioscience Entrepreneur’s
Story: Craig M. Crews, Ph.D.

video-icon-Crews-200px

Talent Wanted/Talent Available

> Connecticut BioScience Job Listings
> BioScience Résumés

Click Here

Bioscience ClubhouseCT and Career Ladder Grant

Applications now being accepted. Get the details.
Click Here